Director · Tempest Therapeutics, Inc. · Tempest Therapeutics, Inc. — Stock Option (right to buy)
Side
A
Value
—
Shares
1,230
Price
—
Executed
Jan 27, 2026
Disclosed
Jan 28, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 27 executedJan 28, 2026 disclosed
TPST · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Tempest Therapeutics, Inc. — Stock Option (right to buy)
Ticker
TPST
Shares
1,230
Price per share
$0
Execution date (reported)
Jan 27, 2026
Owned after transaction
1,230 shares
Days from execution to publication
1
What this establishes
Simantov Ronit filed this Form 4 reporting a grant or award of TPST on Jan 27, 2026. It became public on Jan 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Simantov Ronitcik:0001871563
Issuer
Tempest Therapeutics, Inc.cik:0001544227
Revision history · 0
No field has changed since this record was first ingested.
